Company intelligence / Profile preview

Symporter Bioscience

New York, NY, USAsymporterbiosciences.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Symporter Bioscience is a New York City-based biotech company developing precision genetic therapies. The company is transitioning into the preclinical stage and aims to address fundamental challenges in gene delivery for unmet medical needs. No clinical results have been published yet as they are preclinical

Therapeutic areas: Other
Modalities: Gene therapyGenetic therapies (precision genetic therapies)
Industry: Biotech

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Symporter Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symporter Bioscience.

Explore the full profile